BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19211612)

  • 1. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.
    Shintani M; Yagi H; Nakayama T; Saji T; Matsuoka R
    J Med Genet; 2009 May; 46(5):331-7. PubMed ID: 19211612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension.
    Chida A; Shintani M; Nakayama T; Furutani Y; Hayama E; Inai K; Saji T; Nonoyama S; Nakanishi T
    Circ J; 2012; 76(6):1501-8. PubMed ID: 22374147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective pulmonary vascular remodeling in Smad8 mutant mice.
    Huang Z; Wang D; Ihida-Stansbury K; Jones PL; Martin JF
    Hum Mol Genet; 2009 Aug; 18(15):2791-801. PubMed ID: 19419974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
    Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
    PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
    Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
    Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
    Morty RE; Nejman B; Kwapiszewska G; Hecker M; Zakrzewicz A; Kouri FM; Peters DM; Dumitrascu R; Seeger W; Knaus P; Schermuly RT; Eickelberg O
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1072-8. PubMed ID: 17347486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in a Polish population of patients with pulmonary arterial hypertension: sequencing of BMPR2, ALK1, and ENG genes.
    Uznańska-Loch B; Wikło K; Kulczycka-Wojdala D; Szymańska B; Chrzanowski Ł; Wierzbowska-Drabik K; Trzos E; Kasprzak JD; Kurpesa M
    Kardiol Pol; 2018; 76(5):852-859. PubMed ID: 29350394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counselling in a national referral centre for pulmonary hypertension.
    Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
    Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
    Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
    Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
    Nasim MT; Ogo T; Ahmed M; Randall R; Chowdhury HM; Snape KM; Bradshaw TY; Southgate L; Lee GJ; Jackson I; Lord GM; Gibbs JS; Wilkins MR; Ohta-Ogo K; Nakamura K; Girerd B; Coulet F; Soubrier F; Humbert M; Morrell NW; Trembath RC; Machado RD
    Hum Mutat; 2011 Dec; 32(12):1385-9. PubMed ID: 21898662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis of pulmonary arterial hypertension.
    Ma L; Chung WK
    Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.
    Wang H; Li W; Zhang W; Sun K; Song X; Gao S; Zhang C; Hui R; Hu H
    Eur J Hum Genet; 2009 Aug; 17(8):1063-9. PubMed ID: 19223935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
    Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
    Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.
    Pfarr N; Fischer C; Ehlken N; Becker-Grünig T; López-González V; Gorenflo M; Hager A; Hinderhofer K; Miera O; Nagel C; Schranz D; Grünig E
    Respir Res; 2013 Jan; 14(1):3. PubMed ID: 23298310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and genomics of pulmonary arterial hypertension.
    Machado RD; Eickelberg O; Elliott CG; Geraci MW; Hanaoka M; Loyd JE; Newman JH; Phillips JA; Soubrier F; Trembath RC; Chung WK
    J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S32-S42. PubMed ID: 19555857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.